2. Patient reported outcomes - what Patient Reported Outcomes should be measured within an ERP? 3. Postoperative Gastrointestinal Dysfunction – how can be best prevent and manage postoperative gastrointestinal dysfunction within an ERP The 3rd POQI Consensus Conference will occur in London in July 2017. The subject of the conference will be perioperative blood pressure management. The key figures and manuscript will be made available whenever possible on the POQI website, poqi.us. The POQI process aims to combine a “thorough review of the literature” with “expert appraisal and debate” to offer practical advice that is sometimes missing from consensus statements that purely review the literature. It is based on the longstanding Acute Dialysis Quality Initiative (ADQI) that has been particularly successful in generating consensus definitions and classification systems (including the RIFLE classification for Acute Kidney Injury) Whilst this approach is not without criticism, we believe that this methodology provides the best of both methods, and hopefully the POQI manuscripts that are supported by ASER will provide practical consensus statements and recommendations to guide practice. n Valuable insight to help you guide volume administration. Clarity gives you the control to make more informed decisions. Edwards Lifesciences’ range of hemodynamic monitoring solutions provides key fl ow parameters shown to be more informative in determining fl uid responsiveness than pressure-based parameters.1 Each off ers continuous information which may be used in Perioperative Goal-Directed Therapy (PGDT) to hemodynamically optimize your moderate to high-risk surgery patients. The Edwards Enhanced Surgical Recovery Program can help you implement PGDT today. PGDT can help ensure your patients are consistently maintained in the optimal volume range. Know more. Know now. Edwards.com/ASER17 1. Michard F, Biais M. Rational fl uid management: dissecting facts from fi ction. Br J Anaesth 2012 For professional use. CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events. Edwards Lifesciences devices placed on the European market, meet the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC, and bear the CE marking of conformity. Edwards, Edwards Lifesciences, the stylized E logo, ClearSight, Enhanced Surgical Recovery Program, FloTrac and Swan-Ganz are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners. © 2017 Edwards Lifesciences Corporation. All rights reserved. AR11991 Edwards Lifesciences • One Edwards Way, Irvine CA 92614 USA • edwards.com ASER ALERT • VOLUME 2, ISSUE 1 • aserhq.org 7 ClearSight noninvasive system CO, SV, SVV, SVR, cBP* FloTrac minimally-invasive system CO, SV, SVV, SVR Swan-Ganz system CCO, RVEDV, RVEF, SvO2 * Continuous Blood Pressure Delegates at the 2nd References 1. 2. Consensus Conference. Miller TE, Mythen MG, Shaw AD, Gan TJ. Evidence-Based Perioperative Medicine comes of age: the Perioperative Quality Initiative (POQI). Periop Med 2016; 5:26 Thiele RH, Raghunathan K, Brudney CS, et al. American society for enhanced recovery (ASER) and perioperative quality initiative (POQI) joint consensus statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery. Periop Med 2016; 5:24
8 Publizr Home